The chart below shows the first 6 month results from an 11-month independent study at Manchester Royal Infirmary (MRI). The results show that Byotrol significantly out performed the NHS gold standard bleach week on week.
The AzoMaxActiveTM product range manufactured by Synergy Health and containing ByotrolTM technology was used in the study. The study was supervised by TrusTECH, The NHS's Innovation Hub in the North West of England.
The large-scale MRI study involved four general medical wards and the taking of Swabs, checking for levels of bacteria, from more than 4,000 individual sites. From the start Byotrol matched the performance of bleach and after a few weeks produced a significant drop in bacterial levels on the ward and then continued to outperform bleach throughout the study.
The trial followed a "crossover format" in which Byotrol was used on two wards for six months then used on the two bleach-cleaned control wards for another five months. Its advantage over bleach was maintained throughout the trial.
Byotrol has one more significant advantage over bleach (which is harmful when in contact with patients and even the cleaners who use it). Byotrol is not toxic and can be used in close proximity to patients without harming them.
It can also be used to put on hands and can be used as wipes which gives it an even greater capacity to combat the spread of infections from person to person. This means Byotrol can be used much more broadly across hospitals, as opposed to current NHS practice that limits the regular use of bleach to all but the most high-risk areas in hospitals.
This page has no template. (Page Name: Page ID: )